Literature DB >> 15689401

Predictors of renal allograft histologic damage progression.

Fernanda Ortiz1, Timo Paavonen, Tom Törnroth, Petri Koskinen, Patrik Finne, Kaija Salmela, Lauri Kyllönen, Carola Grönhagen-Riska, Eero Honkanen.   

Abstract

The objective of this study was to analyze factors that are involved in the progression of renal allograft damage in the first 6 mo after transplantation. Donor and 6-mo protocol biopsies of 83 patients who received a renal transplant were classified using the Chronic Allograft Damage Index (CADI). Histologic changes were compared and correlated to clinical parameters at transplantation, at 6 mo, and annually over 2 yr. All CADI components increased significantly in the 6-mo posttransplantation period, except chronic vascular changes and the percentage of glomerulosclerosis. Total cholesterol and LDL- cholesterol at the time of biopsy correlated positively with mesangial matrix increase, and HDL cholesterol correlated negatively with vascular intima increase. High BP at biopsy was associated with tubular atrophy. Diastolic BP at biopsy correlated with 6-mo CADI (CADI-6). Patients with diastolic BP > or =85 mmHg at biopsy had a higher difference between CADI score in protocol biopsies and CADI score in donor biopsies (DeltaCADI) and higher creatinine at 1 and 2 yr. CADI in donor biopsies (CADI-0) >1 was more frequently found in older (odds ratio [OR], 1.07; 95% confidence interval [CI], 1.01 to 1.14) and nontraumatic dead donors (OR, 3.89; 95% CI, 1.13 to 13.33). CADI-6 >3 was more frequently found in those with CADI-0 >1 (OR, 3.82; 95% CI, 1.19 to 12.21), older donors (OR, 1.05; 95% CI, 1.01 to 1.10), and number of AB mismatches (OR, 2.36; 95% CI, 1.09 to 5.10). CADI-0, CADI-6, and DeltaCADI correlated significantly with serum creatinine at hospital discharge, at 6 mo, and at 2 yr. DeltaCADI was affected by initial percentage of glomerulosclerosis (OR, 1.10; 95% CI, 1.02 to 1.19) and creatinine at hospital discharge (OR, 1.01; 95% CI, 1.00 to 1.02). Donor-related as well as nonimmunologic factors, such as hypertension and dyslipidemia, are associated with increased risk for renal allograft damage progression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15689401     DOI: 10.1681/ASN.2004060475

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  10 in total

1.  CYP3A5 *1 allele associated with tacrolimus trough concentrations but not subclinical acute rejection or chronic allograft nephropathy in Japanese renal transplant recipients.

Authors:  Shigeru Satoh; Mitsuru Saito; Takamitsu Inoue; Hideaki Kagaya; Masatomo Miura; Kazuyuki Inoue; Atsushi Komatsuda; Norihiko Tsuchiya; Toshio Suzuki; Tomonori Habuchi
Journal:  Eur J Clin Pharmacol       Date:  2009-01-06       Impact factor: 2.953

2.  Progressive histological damage in renal allografts is associated with expression of innate and adaptive immunity genes.

Authors:  Maarten Naesens; Purvesh Khatri; Li Li; Tara K Sigdel; Matthew J Vitalone; Rong Chen; Atul J Butte; Oscar Salvatierra; Minnie M Sarwal
Journal:  Kidney Int       Date:  2011-08-31       Impact factor: 10.612

Review 3.  Molecular pathways involved in loss of graft function in kidney transplant recipients.

Authors:  Valeria R Mas; Kellie J Archer; Mariano Scian; Daniel G Maluf
Journal:  Expert Rev Mol Diagn       Date:  2010-04       Impact factor: 5.225

Review 4.  Update on ischemia-reperfusion injury in kidney transplantation: Pathogenesis and treatment.

Authors:  Maurizio Salvadori; Giuseppina Rosso; Elisabetta Bertoni
Journal:  World J Transplant       Date:  2015-06-24

5.  Subclinical inflammation and chronic renal allograft injury in a randomized trial on steroid avoidance in pediatric kidney transplantation.

Authors:  M Naesens; O Salvatierra; M Benfield; R B Ettenger; V Dharnidharka; W Harmon; R Mathias; M M Sarwal
Journal:  Am J Transplant       Date:  2012-06-13       Impact factor: 8.086

6.  The role of procurement biopsies in acceptance decisions for kidneys retrieved for transplant.

Authors:  Bertram L Kasiske; Darren E Stewart; Bipin R Bista; Nicholas Salkowski; Jon J Snyder; Ajay K Israni; Gretchen S Crary; John D Rosendale; Arthur J Matas; Francis L Delmonico
Journal:  Clin J Am Soc Nephrol       Date:  2014-02-20       Impact factor: 8.237

7.  Antihypertensive pharmacotherapy and long-term outcomes in pediatric kidney transplantation.

Authors:  Thomas M Suszynski; Michael D Rizzari; Kristen J Gillingham; Michelle N Rheault; Wojciech Kraszkiewicz; Arthur J Matas; Blanche M Chavers
Journal:  Clin Transplant       Date:  2013-05-06       Impact factor: 2.863

8.  Expression of decoy receptor 3 in kidneys is associated with allograft survival after kidney transplant rejection.

Authors:  Shuo-Chun Weng; Kuo-Hsiung Shu; Ming-Ju Wu; Mei-Chin Wen; Shie-Liang Hsieh; Nien-Jung Chen; Der-Cherng Tarng
Journal:  Sci Rep       Date:  2015-09-03       Impact factor: 4.379

Review 9.  Biological pathways and potential targets for prevention and therapy of chronic allograft nephropathy.

Authors:  Badri Man Shrestha; John Haylor
Journal:  Biomed Res Int       Date:  2014-05-27       Impact factor: 3.411

10.  Reliability of pre-transplant live donor renal biopsies in predicting the graft outcome.

Authors:  G H Naderi; M Sotoudeh; D Mehraban; S Nategh
Journal:  Int J Organ Transplant Med       Date:  2014
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.